Clinical Trial to Reduce Hepatitis B Vertical Transmission in Africa
The REVERT-B study aims to test antiviral medication in high-risk pregnant women and newborns to prevent hepatitis B transmission.
Indication
Clinical and regulatory intelligence for Hepatitis B with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.